Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. - Thigpen,J.T.; Blessing,J.A.; Beecham,J. (J Clin Oncol, 1991)